Quick Answer
Lipocine Inc. reported Net Income of -$9.63 million for fiscal year 2025.
Lipocine Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$9.63M | -115371.9% |
| 2024 | $8.4K | +100.1% |
| 2023 | -$16.35M | -52.0% |
| 2022 | -$10.76M | -1595.9% |
| 2021 | -$634.4K | +97.0% |
| 2020 | -$20.96M | -61.2% |
| 2019 | -$13.01M | -11.6% |
| 2018 | -$11.66M | +44.4% |
| 2017 | -$20.98M | -10.6% |
| 2016 | -$18.97M | -4.2% |
| 2015 | -$18.21M | +10.6% |
| 2014 | -$20.37M | -92.4% |
| 2013 | -$10.59M | -372.5% |
| 2012 | $3.89M | +75398.4% |
| 2011 | -$5.2K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.19M | -43.6% | -44.5% |
| June 30, 2025 | -$2.21M | +28.1% | -18.3% |
| March 31, 2025 | -$1.86M | -153.1% | +16.0% |
| September 30, 2024 | -$2.22M | +66.6% | +27.7% |
| June 30, 2024 | -$3.07M | +13.5% | -187.3% |
| March 31, 2024 | $3.51M | +190.8% | +152.8% |
| September 30, 2023 | -$6.65M | -176.1% | -87.4% |
| June 30, 2023 | -$3.55M | -34.8% | +8.3% |
- Lipocine Inc. showed a decrease of -115371.9% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, Lipocine Inc.’s net income has declined by 186407.3% (from -$5.2 thousand to -$9.63 million).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: